We found that for AI transporters in all tubular regions, approximately 78–86% of the AIP cell population expressed SLC22A11 but not SLC22A12, and less than 5% of the AIP cell population expressed both SLC22A11 and SLC22A12 (Additional file 1: Fig. S2H). Here, SLC22A12 is linked to autoimmune pancreatitis.